Author

Sylvie Gomez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Alberto RomagnoniiD· 1 shared Alex J. CornishiD· 1 shared Alice Mac KainiD· 1 shared Almoatazbellah YoussefiD· 1 shared Cécilia Jeannu· 1 shared Chiara SagliettiiD· 1 shared Constance Petit· 1 shared Ekaterina RozhavskayaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alberto RomagnoniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of non-covalent inhibitors for the atypical peroxiredoxin PRDX5 as a therapeutic strategy in malignant pleural mesothelioma

Josep Monserrat, Floriane Montanari, Victor Laurent, Pierre‐Benoit Ancey, Nicolas Jean, Cécilia Jeannu, Guimin Wang, Genshu You, Qiancheng Shen, Alice Mac Kain, Yacine Barèche, Loïc Herpin, Nadia Jeremiah, Roberta Codato, Alberto Romagnoni, , Elodie Pronier

The paper identifies non-covalent inhibitors of PRDX5, a protein upregulated in MPM, through a machine learning guided pipeline and biochemical validation, suggesting it as a therapeutic target.

bioRxiv · May 15, 2026 · PreprintCancer Biology